Surfacide Unveils Helios®+ UV-C System: The First Whole Room Microbial Reduction Device to Receive 510(k) Clearance from the U.S. Food and Drug Administration

Helios+ is the only FDA Class II Medical Device for Whole Room Microbial Reduction using continuous 254 nm germicidal UV light and 3 Emitters in a Single Cycle  (Waukesha, WI) – June 3, 2025 – Surfacide, the industry leader in UV-C technology, is proud to announce the launch of its Helios+ UV-C System, the first […]

Read More… from Surfacide Unveils Helios®+ UV-C System: The First Whole Room Microbial Reduction Device to Receive 510(k) Clearance from the U.S. Food and Drug Administration

Surfacide’s T.J. Krasun Earns Leapfrog Certified Coach Designation

coach in office at easel

Surfacide is proud to announce T.J. Krasun, Vice President, Sales & Customer Experience, has earned his certification as a Leapfrog Certified Coach. Leapfrog’s Certified Coach Training is geared toward healthcare consultants, solution providers, and innovation partners who offer services, products, and technology designed to improve patient safety and healthcare quality in the thousands of hospitals […]

Read More… from Surfacide’s T.J. Krasun Earns Leapfrog Certified Coach Designation

Surfacide Announces Giveaways at 2024 APIC Annual Conference

general tradeshow floor

Leading UV technology and Infections Solutions Company Unveils Product Offerings at Upcoming Industry Conference  Surfacide, a leading UV technology and infections solutions company is proud to announce its participation and exclusive promotions at the upcoming APIC Annual Conference and Exposition in San Antonio, Texas, June 3-5. At this premiere event, the world of infection prevention […]

Read More… from Surfacide Announces Giveaways at 2024 APIC Annual Conference

Surfacide Launches New, Robust Customer Portal

New Portal Enhances Top-Notch SURFcare Customer Service Program with Redesigned Dashboard and Reporting Capabilities, Allowing Customers to Analyze Data to Maximize Usage of Their Surfacide Helios UV-C Microbial Reduction System   (Waukesha, WI) – February 20, 2024– Surfacide, a leader in UV-C microbial reduction technology, recently launched a new, redesigned customer portal, part of their SURFcare […]

Read More… from Surfacide Launches New, Robust Customer Portal

Surfacide Appoints T.J. Krasun To Vice President of Sales And Customer Experience

TJ Krasun VP Sales 2024

Promotion Signifies Exciting New Opportunities and Announcements Forthcoming in 2024 Surfacide is very pleased to announce that T.J. Krasun, former Group Sales Director for Surfacide, has stepped into a new role as Vice President (VP) of Sales and Customer Experience. In his new role, T.J. will provide all day-to-day sales leadership to the Surfacide sales […]

Read More… from Surfacide Appoints T.J. Krasun To Vice President of Sales And Customer Experience

Surfacide® Announces Exclusive Distribution of PathTrac®, A Cutting-Edge Clinical Decision Support Software Platform

Showing transmission pathways in the OR

PathTrac Data Helps Hospitals Pre-Empt SSI’s Before They Occur By Identifying, Monitoring, and Enhancing Operating Room Infection Prevention Protocols (Waukesha, WI and ORMC Booth #926) – September 18, 2023– Surfacide, the  leader in UV-C microbial reduction technology, has announced they are the exclusive partner and provider of PathTrac, an innovative clinical decision support software platform […]

Read More… from Surfacide® Announces Exclusive Distribution of PathTrac®, A Cutting-Edge Clinical Decision Support Software Platform

St. Bernard Hospital Accepts In-Kind Donation of Surfacide’s State-of-the-Art UV-C Microbial Reduction Technology

Valued at $100,000, the technology system will support environmental services staff in maintaining clean and safe patient facilities Chicago, IL – Today, representatives from Surfacide announced an in-kind donation of their industry-leading infection prevention technology to St. Bernard Hospital to help the safety net hospital maintain its high standards for patient safety. Just as the […]

Read More… from St. Bernard Hospital Accepts In-Kind Donation of Surfacide’s State-of-the-Art UV-C Microbial Reduction Technology

Surfacide Announces Partnership with The Leapfrog Group

Surfacide Leapfrog partner image

Surfacide today announced its partnership with The Leapfrog Group, an independent national watchdog organization of employers and other purchasers focused on health care safety. Surfacide is represented by Gunner Lyslo, founder and CEO, who sits on the Leapfrog Partners Advisory Committee. Based in Washington, DC, The Leapfrog Group was founded in 2000 with the goal […]

Read More… from Surfacide Announces Partnership with The Leapfrog Group

Surfacide® Launches SURFrx UVC Microbial Reduction Program Specifically for Pharmacy Sterile Compounding Rooms

The Program Addresses Upcoming Regulatory Changes to USP <797> and <800> With an Affordable, Monthly Microbial Reduction Plan for Pharmacy “Clean Rooms” to Help Achieve Best Practices in Environmental Compliance (Waukesha, WI and ASHP Booth #710) – June 7, 2023– Surfacide, a leader in UV-C microbial reduction technology, has announced SURFrx, a new evidence-based, UV-C […]

Read More… from Surfacide® Launches SURFrx UVC Microbial Reduction Program Specifically for Pharmacy Sterile Compounding Rooms